Spots Global Cancer Trial Database for Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Official Title: Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Study ID: NCT00997594
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
Detailed Description: Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release during RF ablation is considered the cause of hypertension. But there has been no evidence that adrenal hormones affects changes in blood pressure. In this prospective study, we evaluate the changes in adrenal hormones during RF ablation and clarify the cause of hypertensive crisis.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mie University Hospital, Tsu, Mie, Japan
Mie University, Tsu, Mie, Japan
Contact Details
Name: Koichiro Yamakado, MD
Affiliation: Mie University School of Medicine
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
